<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02687347</url>
  </required_header>
  <id_info>
    <org_study_id>15-369 MP-CUSM</org_study_id>
    <nct_id>NCT02687347</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain</brief_title>
  <acronym>UDOME</acronym>
  <official_title>A Double Blind Randomized Clinical Trial to Investigate the Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic Therapy in Cancer Patients With Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research hypothesis of this study is: In patients with moderate to severe cancer related
      pain, the addition of low dose methadone to an existing opioid significantly reduces pain
      severity compared to low doses morphine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain relief</measure>
    <time_frame>2 months</time_frame>
    <description>1) Pain item of the Edmonton Symptom Assessment Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain relief</measure>
    <time_frame>2 months</time_frame>
    <description>Questions 3 to 6 of the Brief Pain Inventory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0&quot;.</measure>
    <time_frame>2 months</time_frame>
    <description>prevalence and severity of opioid induced side effects</description>
  </secondary_outcome>
  <other_outcome>
    <measure>pain interference</measure>
    <time_frame>2 months</time_frame>
    <description>Brief Pain Inventory: Composite questions 9-A to 9-G</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Pain, Intractable</condition>
  <arm_group>
    <arm_group_label>study arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low dose methadone (1-10mg daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>low dose morphine (1-10 mg/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral methadone</intervention_name>
    <description>Oral methadone is the study drug</description>
    <arm_group_label>study arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral morphine</intervention_name>
    <description>Oral morphine is the active comparator. It is not a placebo intervention</description>
    <arm_group_label>control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed of cancer-related pain of more than 3 months duration

          -  Pain relief during the last week rated unsatisfactory by the patient

          -  Pain severity during the last week rated moderate (between 4 and 7/10)

          -  Analgesic therapy must have been stable for 7 days

          -  Able to understand English or French

          -  Willing and able to give written informed consent

        Exclusion Criteria:

          -  Patients who are currently receiving or have received methadone as analgesic in the
             last 6 months

          -  Contraindication to receive methadone (allergy, QTc segment on the ECG&gt;450msec,
             concurrent treatment with medication that could increase methadone's effects)

          -  Patients presenting with changes in their cancer status/treatment with potential
             effects on their pain severity, during the duration of the trial (eg: new metastasis,
             indication for radiotherapy)

          -  Patients whose life expectancy is shorter than 2 months

          -  Patients with cognitive impairment presenting with difficulties understanding the
             trial and completing the research questionnaires

          -  Pregnant or lactating women (women of childbearing potential must have negative
             pregnancy test)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alan Edwards Pain Management Unit. Mcgill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordi Perez, MD</last_name>
      <phone>5149348222</phone>
      <email>jordi.perez@muhc.mcgill.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2016</study_first_submitted>
  <study_first_submitted_qc>February 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2016</study_first_posted>
  <last_update_submitted>September 16, 2016</last_update_submitted>
  <last_update_submitted_qc>September 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Jordi Perez</investigator_full_name>
    <investigator_title>Codirector Cancer Pain Program. McGill University Health Centre. Montreal, Canada</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Intractable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Demographic, cancer status, pain medication, symptom severity and side effects profile will be collected for each participant throughout the study
Data will be collected by clinical interview with research nurse
Data will be available to researchers immediately</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

